MeTopic Cream

Manufacturer
Method Pharmaceuticals, LLC
Effective date
2018-04-10
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:00:17

Label at a glance#

ProductMeTopic
Active ingredientUREA
Label structure10 sections

Dosage and administration

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed. See package insert for full prescribing information.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

NDC 58657-485-08

MeTopic Cream

(Urea 41%)

For External Use Only Rx Only

Net Wt. 8 oz. (227 g

MeTopic

Method Pharmaceuticals, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

----------

MeTopic Cream DESCRIPTION:

Each gram contains 410 mg of urea in a vehicle consisting of: ceteareth-25, ceteareth-6, cetyl alcohol, methylparaben, paraffin, propylene glycol, propylparaben, purified water, stearyl alcohol, xanthan gum.

Urea is a diamide of carbonic acid with the following chemical structure:

The following chemical structure for Urea is a diamide of carbonic acid. Each gram contains 410 mg of urea in a vehicle consisting of: ceteareth-25, ceteareth-6, cetyl alcohol, ...The following chemical structure for Urea is a diamide of carbonic acid. Each gram contains 410 mg of urea in a vehicle consisting of: ceteareth-25, ceteareth-6, cetyl alcohol, ...

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Pharmacokinetics: The mechanism of action of topically applied urea is not yet known.

INDICATIONS:

INDICATIONS & USAGE SECTION

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS:

WARNINGS SECTION

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. KEEP OUT OF REACH OF CHILDREN.

Avoid contact with eyes, lips and mucous membranes.

General:

GENERAL PRECAUTIONS SECTION

This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Information for Patients:

INFORMATION FOR PATIENTS SECTION

Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

Carcinogenesis, Mutagenesis and Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Pregnancy:

PREGNANCY SECTION

Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

See package insert for full prescribing information.

STORAGE:

SAFE HANDLING WARNING SECTION

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

NOTICE: Protect from freezing and excessive heat. Keep bottle tightly closed.

HOW SUPPLIED:

HOW SUPPLIED SECTION

This product is supplied in the following size(s): 8 oz. (227 g) bottles, NDC # 58657-485-08

To report a serious adverse event or obtain product information, call 877-250-3427

To report a serious adverse event, please contact Method Pharmaceuticals at (877) 250-3427; email at contact@methodpharm.com; or call FDA at (800) FDA-1088.

Manufactured for:

Method Pharmaceuticals, LLC Fort Worth, Texas 76118

Rev. 03/18

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 58657-485-08
MeTopic 
Cream
(Urea 41%)
For External Use Only
Rx Only
Net Wt. 8 oz. (227 g)

PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g)PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g) PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g)PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g)

PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g)PRINCIPAL DISPLAY PANEL NDC 58657-485-08 MeTopic Cream (Urea 41%) For External Use Only Rx Only Net Wt. 8 oz. (227 g)

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58657-485-082020-02-17C16284748780-19d75b9cf-f92c-f424-e053-dadaa90a57ceMeTopic Cream
58657-485-082020-01-31C16284748780-19d75b9cf-f92c-f424-e053-dadaa90a57ceMeTopic Cream

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58657-485-08GM - Gram58657-485aba4c1e9-58fc-496b-8eff-300d43cb47f412018-05-09

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58657-48558657-485-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2fcf6663-20b9-4432-9e3c-3ea44912a8242072755e-1da3-4f8a-9b05-1a34610ad2972018-04-10Warnings, Adverse reactionsExact identifier
spl id: 2fcf6663-20b9-4432-9e3c-3ea44912a824
spl set id: 2072755e-1da3-4f8a-9b05-1a34610ad297

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.